Can I take weight loss injections? What actually determines the answer

The biggest misconception: these injections are available to anyone who wants to lose weight

This is the question our prescribers hear most weeks, and it usually comes with an assumption underneath it: that the injections are freely available to anyone carrying extra weight. They are not. Mounjaro and Wegovy are prescription-only medicines. In the UK that means a qualified prescriber must assess whether treatment is clinically appropriate for you specifically, taking into account your BMI, your medical history, any medicines you already take, and any conditions that might make these treatments unsuitable. You cannot buy them over the counter, and a seller offering them without that assessment is operating outside the law.

That said, the eligibility criteria are genuinely broad. Most adults with a BMI at or above 30 will fall within the licensed range, as will adults from BMI 27 upwards who have a weight-related condition. High blood pressure, pre-diabetes, type 2 diabetes, obstructive sleep apnoea, high cholesterol and osteoarthritis all count. So for a large proportion of people asking this question, the honest answer is: quite possibly yes — but a prescriber needs to confirm it. The full eligibility picture for weight loss injections covers the medical criteria in more detail.

Lower BMI thresholds apply for some ethnic backgrounds under UK clinical guidance, meaning a South Asian, Chinese, Middle Eastern, Black African or African-Caribbean adult may qualify at a BMI 2.5 kg/m² below the standard threshold. This is not a minor detail, it reflects genuine differences in cardiometabolic risk at lower body weights.

Situations where weight loss injections are not recommended

Understanding who should not take these medicines is just as important as knowing who can. Neither Mounjaro nor Wegovy is licensed for use during pregnancy, and both are not recommended while breastfeeding or when actively trying to conceive. If you become pregnant while on treatment, stopping and speaking to your GP promptly is the right step.

For people using oral contraceptives, tirzepatide (Mounjaro) specifically warrants extra caution. Because it slows gastric emptying, it can reduce how well the contraceptive pill is absorbed. NHS guidance advises adding a non-oral contraceptive method, such as condoms, for the first four weeks of treatment and for four weeks after each dose increase. There is no equivalent evidence of this effect for semaglutide (Wegovy), but any contraception questions are worth raising at your consultation. You can read more on the practical aspects of taking the weight loss injection, including contraception considerations.

Neither medicine is licensed for anyone under 18. People with a personal or family history of medullary thyroid carcinoma, or a condition called MEN2, should not take GLP-1 medicines. A history of pancreatitis also requires careful prescriber discussion. These are the kinds of details a proper clinical assessment is designed to surface, which is exactly why the assessment exists. The question of whether anyone can take these injections explores the exclusion criteria in full.

What the actual assessment involves, and what side effects to be aware of

A clinical consultation for weight loss injections is not a form you fill out and instantly receive a parcel. At nume, a GPhC-registered Independent Prescriber reads your responses personally, on the same day, and may contact you if clarification is needed. Identity is verified by photo ID, and weight is confirmed on a live video call. This is what legitimate, regulated access looks like, and it is also how the prescriber spots the situations where treatment is not right for someone.

On the side-effect side, both medicines share a similar profile, led by gastrointestinal symptoms: nausea, vomiting, diarrhoea, constipation, indigestion and fatigue are the most commonly reported. These tend to be most noticeable in the first weeks or after a dose step, and they usually ease as the body adjusts. Severe, persistent stomach pain that radiates to the back needs urgent medical attention because it can signal pancreatitis, an uncommon but serious risk flagged by the MHRA's Drug Safety Update of January 2026. Anyone on these medicines should know that signal and act on it quickly.

Injection sites include the abdomen, thigh and upper arm, and rotating them helps avoid local reactions. If needles are a concern, the newer Wegovy 7.2mg pen has a covered, auto-activating mechanism, and oral semaglutide (Wegovy tablets) became available in the UK as a tablet alternative in June 2026. Storage for the injectable versions is refrigerated, and the specific temperature window is detailed in the Patient Information Leaflet that comes with each pen. How long you might stay on treatment is a separate clinical question covered on the page about how long weight loss injections can be taken.

NHS access versus a private prescription: what changes and what does not

Even if you meet the eligibility criteria, access through the NHS is not straightforward right now. NICE's recommendation for tirzepatide (TA1026) sets NHS eligibility at BMI 35 or above with at least one qualifying comorbidity, within a phased rollout that expanded to a second cohort in June 2026. Semaglutide through the NHS is conditional on referral to a specialist weight management service, with criteria outlined in NICE TA875. Waiting lists for these services are commonly long in most areas.

A private prescription bypasses the waiting list but not the clinical assessment. The prescriber's job is the same: to establish that treatment is appropriate and safe for you. If you are curious about the cost side of private treatment, what weight loss injections cost privately sets out the market context honestly. At nume, one transparent price covers consultation, prescription, medicine and free next-working-day delivery, with no subscription and no auto-renewal. Every repeat order is reviewed clinically before anything is sent.

If you think you may be a candidate, starting a free consultation with our prescribers is the sensible next step. You'll get a clear answer rather than a guess.